tiprankstipranks
Trending News
More News >
Lipigon Pharmaceuticals AB (DE:9RP)
FRANKFURT:9RP

Lipigon Pharmaceuticals AB (9RP) Revenue

Compare
0 Followers

Lipigon Pharmaceuticals AB Revenue

Lipigon Pharmaceuticals AB had a revenue of 0.00 in the quarter ending Sep 30, 2025, with ―. This bring the company's revenue in the last twelve months to 1.36M, Increased -0.07%. In the fiscal year ending Dec 31, 2024, Lipigon Pharmaceuticals AB had annual revenue of 10.29M with -37.30% growth.
Revenue (ttm)
1.36M
Revenue Growth
P/S Ratio
0.04
Revenue/Employee
€1,714,500
Employees
6
Market Cap
€460.79K

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
10.29M-6.12M+62.70%
Dec 31, 2023
16.41M16.02M+4,206.93%
Dec 31, 2022
390.00K-2.79M+12.26%
Dec 31, 2021
3.18M-1.10M+74.33%
Dec 31, 2020
4.28M2.54M+245.44%
Dec 31, 2019
1.74M1.73M+9,683.87%
Dec 31, 2018
18.00K-1,800,000.00%
Dec 31, 2017